Maggot wound treatment with images
maggot wound treatment myiasis clinical images debridement



| Step | Action |
|---|---|
| 1 | Check maggot viability - confirm larvae moving in the vial |
| 2 | Apply protective skin prep (e.g., benzoin) to skin around wound |
| 3 | Cut a hydrocolloid "donut" dressing to fit around the wound perimeter (2-3 cm margin) |
| 4 | Apply hydrocolloid donut securely, wrinkle-free |
| 5 | Apply adhesive (benzoin) to the top of the hydrocolloid |
| 6 | Place plastic trash bag under body part to catch escaped larvae; apply maggots to wound bed using cotton-tipped applicators - dose: 5-8 maggots per cm² of wound area |
| 7 | Cover maggots with damp loosely fluffed gauze to keep wound moist |
| 8 | Apply Dacron/chiffon "cage" fabric over wound, adhered to hydrocolloid - this contains larvae while allowing gas exchange |
| 9 | Cover entire construct with semipermeable transparent dressing (not occlusive - maggots need oxygen) |
| 10 | Change dressing every 48-72 hours |
Do NOT use an occlusive dressing - maggots are aerobic and will die without oxygen access.
| Approach | Details |
|---|---|
| Manual removal | Mechanical extraction of all visible larvae - mainstay of treatment |
| Irrigation | Copious wound irrigation to dislodge larvae |
| Surgical debridement | Usually not required unless patient requests; larvae naturally slough within 5-7 weeks |
| Chemical adjuncts | Chloroform in light vegetable oil or ether applied topically before larval removal under local anesthesia |
| Ivermectin | Off-label use - facilitates larval death; particularly useful for non-extractable screwworm larvae |
| Antibiotics | Broad-spectrum antibiotics for secondary pyogenic infection |
Caution: Always extract larvae whole - a fragmented larva causes significant foreign body reaction. Do NOT forcibly pull larvae that use spines/hooks to grip tissue; apply suffocation techniques first (petroleum jelly, chloroform oil).
Maggot wound treatment with images in dogs
maggot wound treatment dogs fly strike myiasis veterinary clinical images
maggot debridement therapy dogs veterinary MDT larval therapy wound
maggot debridement therapy dogs veterinary wounds
https://www.cliniciansbrief.com/article/managing-maggots-bot…
https://www.vosd.in/treating-maggot-wounds-in-dogs

| Severity | Clinical Signs |
|---|---|
| Mild | Small wound, few visible larvae on surface, dog alert and eating, no systemic signs |
| Moderate | Larger wound, larvae burrowing into tissue, some surrounding necrosis, mild lethargy |
| Severe | Large/deep wound with subcutaneous tunnels, extensive necrosis (grey/black tissue margins), larvae visible as movement from a distance, dog lethargic, febrile, anorexic, possible shock |
Key danger: Larvae secrete proteolytic enzymes that liquefy living tissue, not just necrotic tissue. Crushed or fragmented larvae release these enzymes in large quantities, potentially causing systemic toxaemia and shock.
Do NOT ignore tissue adjacent to the main wound. Larvae migrate. A visible wound may have satellite tunnels several centimetres away.
| Step | Treatment | Details |
|---|---|---|
| 1 | Sedation/anaesthesia | Most cases require sedation - removal is painful and stressful |
| 2 | Clip and expose | Thorough clipping of the entire region to reveal full extent of infestation |
| 3 | Manual larval removal | Careful hand extraction of all visible larvae - the primary treatment |
| 4 | Antiseptic lavage | Chlorhexidine or povidone-iodine wound cleaning and irrigation |
| 5 | Surgical debridement | Excision of necrotic/non-viable tissue; wound may be larger than it appears |
| 6 | Antiparasitic treatment | To kill remaining larvae not visible/accessible |
| 7 | Antibiotics | Broad-spectrum; continue minimum 14 days beyond clinical resolution |
| 8 | Supportive care | IV fluids, analgesia, anti-inflammatories for systemic cases |
| 9 | Wound management | Regular dressing changes; monitor for gangrene and secondary infection |
| Drug | Route | Notes |
|---|---|---|
| Ivermectin | Injectable/oral | Kills remaining larvae; first-line systemic option |
| Nitenpyram | Oral | Fast-acting; reported efficacy |
| Spinosad + milbemycin | Oral | Combination product |
| Isoxazolines (fluralaner, sarolaner, afoxolaner) | Oral | Safe at label doses; effective |
| Pyrethrin | Topical | Applied to wound site in dogs only (NOT cats - toxic) |

| Challenge | Solution |
|---|---|
| Animal removes/chews dressing | Use Elizabethan collar; sedation for dressing changes |
| Maggot containment | Secure cage dressing with chiffon/Dacron and bandaging |
| Animal discomfort | Larvae movement causes itching/irritation; analgesia helps |
| Maggot survival on arrival | Use within 24 hours; keep at room temperature until use |
| Owner acceptance | Educate about controlled, sterile nature of MDT maggots |